EUROPE PERIPHERAL VASCULAR DEVICES MARKET FORECAST 2021-2028

The Europe peripheral vascular devices market is set to record a CAGR of 11.32% during the forecast period, 2021-2028. The growing geriatric population, the changing lifestyle, and the increased cardiac, diabetes, and blood pressure cases, are the important factors driving the market growth of the region.

europe-peripheral-vascular-devices-market

The Europe peripheral vascular devices market growth evaluation includes the analysis of Germany, Poland, the United Kingdom, Italy, France, Belgium, Russia, and Rest of Europe. The increasing healthcare expenditure is one of the primary growth drivers in the United Kingdom. According to Diabetes UK, diabetes patients are more prone to peripheral arterial disease (PAD). As per the Vascular Society for Great Britain and Ireland, PAD is a grave disorder that results in the narrowing of arteries. PAD affects 9% of the UK population. According to the Clinical review: Peripheral vascular disease 2017 article, the PVD (peripheral vascular disease) prevalence in the elderly is around 15-20%. Such factors are expected to increase market growth in the UK.

Italy has a well-developed healthcare system. It entails a national health plan that provides medical and hospital benefits. Individuals with lower extremity PAD are associated with reduced quality of life, cardiovascular morbidity, stroke, mortality, and atherosclerosis. Further, the aging population (aged 65 and above) in 2020 was around 23.2% of the total population. The aging population in Italian society has been projecting constant growth in recent years, as per the Statista data. This further leads to increased age-related vascular diseases. Such factors contribute to the Italy market growth.

Cardinal Health Inc (CORDIS) is a Fortune 500 healthcare services company specializing in distributing medical products and pharmaceuticals. The Cardinal Health branded surgical, laboratory, and medical products are sold in Asia, Europe, Canada, the United States, etc. The company's product portfolio includes INCRAFT AAA Stent Graft System, ANGIOGUARD RX Guidewire System, and PRECISE PRO RX Stent. It is headquartered in Ohio, the United States.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY                
    1. STUDY OBJECTIVES                  
    2. SCOPE OF STUDY                      
    3. METHODOLOGY               
    4. ASSUMPTIONS & LIMITATIONS                       
  2. EXECUTIVE SUMMARY                     
    1. MARKET SIZE & ESTIMATES                
    2. MARKET OVERVIEW                  
  3. MARKET DYNAMICS
    1. KEY DRIVERS       
      1. SURGE IN DEMAND FOR MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE          
      2. GROWING INCIDENCE OF PERIPHERAL ARTERIAL DISEASE                
      3. INCREASING AGING POPULATION AND LIFESTYLE CHANGES             
      4. TECHNOLOGICAL ADVANCEMENTS               
    2. KEY RESTRAINTS           
      1. STRINGENT REGULATIONS                   
      2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES                     
      3. HIGH COMPETITION                      
  4. KEY ANALYTICS                      
    1. IMPACT OF COVID-19 ON PERIPHERAL VASCULAR DEVICES MARKET       
    2. KEY INVESTMENT INSIGHTS               
    3. PORTER’S FIVE FORCES ANALYSIS             
      1. BUYERS POWER
      2. SUPPLIERS POWER         
      3. SUBSTITUTIONS                
      4. NEW ENTRANTS                
      5. INDUSTRY RIVALRY                     
    4. OPPORTUNITY MATRIX             
    5. VENDOR LANDSCAPE               
  5. MARKET BY DEVICE TYPE              
    1. PERIPHERAL VASCULAR STENTS                 
      1. SELF EXPANDING PERIPHERAL VASCULAR STENTS                   
      2. BALLOON EXPANDING PERIPHERAL VASCULAR STENTS                      
      3. DRUG ELUTING PERIPHERAL VASCULAR STENTS           
      4. COVERED STENT              
    2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS             
      1. STANDARD PTA BALLOON CATHETERS                   
      2. HIGH-PRESSURE PTA BALLOON CATHETER                       
      3. LARGE PTA BALLOON CATHETER                   
      4. SMALL PTA BALLOON CATHETER                   
      5. SPECIALTY PTA BALLOON CATHETER                      
      6. DRUG COATED PTA BALLOON CATHETER               
    3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES                    
    4. ATHERECTOMY DEVICES                    
    5. EMBOLIC PROTECTION DEVICES                 
    6. INFERIOR VENA CAVA FILTERS                     
    7. OTHER DEVICE TYPES              
  6. GEOGRAPHICAL ANALYSIS                                    
    1. EUROPE                 
      1. KEY GROWTH ENABLERS                     
      2. KEY CHALLENGES           
      3. KEY PLAYERS                    
      4. COUNTRY ANALYSIS                   
        1. UNITED KINGDOM                            
        2. GERMANY                              
        3. FRANCE                                  
        4. ITALY                            
        5. RUSSIA                       
        6. BELGIUM                                 
        7. POLAND                                  
        8. REST OF EUROPE                                       
  7. COMPETITIVE LANDSCAPE            
    1. KEY STRATEGIC DEVELOPMENTS               
      1. MERGER & ACQUISITIONS                     
      2. PRODUCT LAUNCH & DEVELOPMENTS                    
      3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION              
      4. BUSINESS EXPANSION               
    2. COMPANY PROFILES                 
      1. ABBOTT LABORATORIES           
      2. BOSTON SCIENTIFIC CORPORATION             
      3. BECTON, DICKINSON AND COMPANY            
      4. COOK GROUP                    
      5. CARDINAL HEALTH INC (CORDIS)                   
      6. EDWARDS LIFESCIENCES CORPORATION              
      7. MEDTRONIC PLC               
      8. KONINKLIJKE PHILIPS NV (VOLCANO)           
      9. ANGIOSCORE INC (SPECTRANETICS CORPORATION)                 
      10. TELEFLEX MEDICAL                  
      11. TERUMO INTERVENTIONAL SYSTEMS INC            
      12. ENDOLOGIX
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PERIPHERAL VASCULAR DEVICES

TABLE 2: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: LEADING PLAYERS OPERATING IN EUROPE PERIPHERAL VASCULAR DEVICES MARKET

TABLE 11: LIST OF MERGERS & ACQUISITIONS

TABLE 12: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY DEVICE TYPE, IN 2020

FIGURE 6: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERIPHERAL VASCULAR STENTS, IN 2020

FIGURE 8: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY SELF EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2026 (IN $ MILLION)

FIGURE 12: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, IN 2020

FIGURE 14: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 20: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)

FIGURE 21: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 22: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 23: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)

FIGURE 25: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 26: UNITED KINGDOM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: GERMANY PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: FRANCE PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: ITALY PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: RUSSIA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: BELGIUM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: POLAND PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: REST OF EUROPE PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample